Topics

Companies Related to "acquire celiac therapy developer Sitari Pharmaceuticals" [Most Relevant Company Matches] RSS

20:19 EDT 23rd October 2019 | BioPortfolio

Here are the most relevant search results for "acquire celiac therapy developer Sitari Pharmaceuticals" found in our extensive corporate database of over 50,000 company records.

Showing "acquire celiac therapy developer Sitari Pharmaceuticals" Companies 1–25 of 3,500+

Relevant

Alvine Pharmaceuticals, Inc.

Alvine Pharmaceuticals, Inc. is a private, clinical-stage, specialty biopharmaceutical company located in San Carlos, CA, focused on the development of biologics targeting autoimmune and inflammatory diseases, including celiac disease. Alvine is focusing clinical development efforts on ALV003, an investigational drug in Phase 2 trials that could potentiall...


ImmusanT, Inc.

ImmusanT is a privately held biotechnology company focused on restoring tolerance to gluten in celiac disease by harnessing new discoveries in immunology that aim to improve diagnosis and treatment and return patients to a normal diet, good health and improved quality of life. The company is developing Nexvax2®, a therapeutic vaccine for celiac disease,...

ImmusanT Inc.

ImmusanT is a privately-held biotechnology company focused on restoring tolerance to gluten in celiac disease by harnessing new discoveries in immunology that aim to improve diagnosis and treatment and return patients to a normal diet, good health and improved quality of life. The company is developing Nexvax2®, a therapeutic vaccine for celiac disease,...


Immune Network Ltd.

We are not a traditional biotech company. Industries such as high tech and real estate have their merchant developers - organizations who recognize the potential of an idea or property. They analyze market potential, existing infrastructure and current problems, acquire the project and take it forward to the point of re-sale to another developer or final market. That's what we're doing in the biop...

Actient Pharmaceuticals LLC

Actient Pharmaceuticals is a specialty products company focused on therapeutics to improve patient outcomes. The company was formed to acquire companies and products with a focus on select physician specialties. For more information, please visit www.actientpharma.com.

Triangle Pharmaceuticals Incorporated

Triangle Pharmaceuticals develop new drug candidates primarily in the antiviral area, with a particular focus on therapies for HIV, including AIDS, and the hepatitis B virus ("HBV"). Triangle Pharmaceuticals have an existing portfolio of six licensed drug candidates and one drug candidate for which they have an option to acquire a license. Five of these drug candidates are currently under active d...

Innovive Pharmaceuticals

INNOVIVE Pharmaceuticals is a biopharmaceutical company headquartered in midtown Manhattan. Our mission is to acquire, develop and commercialize novel therapeutics addressing significant unmet medical needs in the fields of oncology and hematology.INNOVIVE is grounded in scientific and technical excellence. We are committed to creating value for employees and shareholders, and for the caregivers a...

The North American Society for the Study of Celiac Disease

Maxinovel Pharmaceuticals, Inc.

Maxinovel Pharmaceuticals, Inc. is a biotech company focusing on the discovery and development of Immuno-oncology therapy and targeted therapy. It will use its orally active Immuno-oncology product platform to bring effective combo product of multi-components in a single oral pill to the patients worldwide. For more info: www.maxinovel.com

Radiation Therapy Services, Inc.

Radiation Therapy Services, Inc. is a leading developer and operator of radiation therapy centers. These centers, which are freestanding and hospital based, provide a full spectrum of radiation therapy services to cancer patients, including conventional external beam radiation treatments as well as advanced services such as prostate seed implants (brachyth...

King Pharmaceuticals

King Pharmaceuticals are a vertically integrated pharmaceutical company that manufactures, markets and sells primarily branded prescription pharmaceutical products. Through a national sales force of over 200 representatives, we marketour branded pharmaceutical products to general/family practitioners and internal medicine physicians and hospitals across the country. King Pharmaceuticals business s...

Incara Pharmaceuticals

Incara Pharmaceuticals Corporation focuses on the protection and regeneration of tissue damaged by injury and disease. The company currently has programs in three areas: liver cell therapy and progenitor cell therapy as a treatment for liver failure; small molecule catalytic antioxidants as treatment for stroke and tissue damage; and deligioparin (formerly named OP2000), an ultra-low molecular wei...

Mevion Medical Systems, Inc.

Mevion Medical Systems, Inc. is a radiation therapy company dedicated to advancing the treatment of cancer. As the pioneering developer of proton therapy systems, Mevion provides innovative, safe and effective solutions by transforming advances in medical technology and science into practical clinical reality.

Nexell Therapeuitcs Incorporated

Nexell Therapeutics Inc.(NASDAQ: NEXL), formerly known as VIMRX Pharmaceuticals Inc., is the leading developer and marketer of innovative diagnostics and ex vivo cell therapies for cancer, autoimmune, metabolic and genetic diseases. Nexell’s lead product, the Isolex® Cell Selection System, is marketed in a number of countries and is currently under final review by the FDA in the United States....

EO2 Concepts

EO2 Concepts is a privately held, advanced wound care technology company and the developer of a progressive FDA-cleared Class II medical device that provides therapy to difficult-to-heal wounds. The TransCu O2 is an electrochemical tissue oxygenation and wound monitoring system for use with OxySpur™ Oxygen Diffusion Dressings as an adjunctive therapy to ...

ImmunogenX

“ImmunogenX” (a subsidiary of Immunogenics LLC) is a clinical-stage company founded in 2013 and is supported by a team of world-renowned clinicians, scientists and advisors in celiac disease research. In addition to the newly-acquired IMGX-003, ImmunogenX is developing an advanced diagnostic tool. For disease management, ImmunogenX is extending a...

Insight Pharmaceuticals Corp.

Insight Pharmaceuticals was founded to acquire niche consumer OTC drug products from larger companies, focusing on their biggest brands. The company's philosophy is to earn customer loyalty and build consumer affinity by offering effective medications which target specific health needs, providing them with maximum relief of their symptoms. Insight has rece...

Savient Pharmaceuticals, Inc.

Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing KRYSTEXXA(TM) (pegloticase) for the treatment of chronic gout in patients refractory to conventional therapy. Savient has exclusively licensed worldwide rights to the technology related to KRYSTEXXA, formerly referred to as Puricase®, from Duke University and Mountain View Pharmaceuticals, Inc. Savient al...

Lipella Pharmaceuticals, Inc.

Lipella Pharmaceuticals Inc., the developer of LP-09, is a specialty biopharmaceutical company focused on the development of topical liposomal formulations for multiple therapeutic applications, including Interstitial Cystitis, Hemorrhagic Cystitis, and Overactive Bladder. LP-09 is not currently approved for commercial use in any indication in the United S...

Apexian Pharmaceuticals

Apexian Pharmaceuticals is a clinical-stage biotechnology company focused on developing safe and effective therapy for patients with high unmet medical needs. Apexian’s lead drug candidate APX3330, is an oral first-in-class novel inhibitor of the APE1 protein, a critical node in cancer cell signaling. To learn more about Apexian Pharmaceuticals, pleas...

Dura Pharmaceuticals

Developer and marketer of prescription pharmaceutical products for the treatment of allergies, asthma and related respiratory conditions.

Rocket Pharmaceuticals, Inc.

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) (“Rocket”) is an emerging, clinical-stage biotechnology company focused on developing first-in-class gene therapy treatment options for rare, undertreated diseases. Rocket’s multi-platform development approach applies the well-established lentiviral vector (LVV) and adeno-associated viral vector (AA...

Vertical Pharmaceuticals, Inc.

Vertical Pharmaceuticals, Inc. is a privately owned pharmaceutical company founded in 2003 with a clear focus in mind – to develop, market, and acquire products offering therapeutic benefits for patients and healthcare providers. The Company specializes in Women’s Health and Pain Management. Our prescription medications are marketed by our dedicated ...

Cytonet GmbH & Co. KG

"Cytonet provides successful solutions to heal life-threatening diseases by using pharmaceuticals based on human cells while using the competence in cell-therapy to extend the world-wide leading position in in vitro and in vivo therapy of heaviest disease of vital parts, especially the liver."

Therapy Source, Inc.

Therapy Source, a premier therapy staffing provider, offers highly qualified speech, occupational, physical, psychological and related therapy services to educational and healthcare organizations. For more information on Therapy Source, visit www.txsource.net or call toll free at 866-783-5301.


More From BioPortfolio on "acquire celiac therapy developer Sitari Pharmaceuticals"

Quick Search

Corporate Database Quicklinks